Ticker
ZYMECompany Name
ZYMEWORKS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 98.25M | 2.55 | $ 38.5M |
3/31/2025 | $ 76.2M | 1.17 | $ 65.1M |
12/31/2024 | $ 66.1M | 0.75 | $ 88.29M |
9/30/2024 | $ 122.36M | 1.46 | $ 83.91M |
6/30/2024 | $ 70.96M | 1.3 | $ 54.71M |
3/31/2024 | $ 114.81M | 2.02 | $ 56.89M |
12/31/2023 | $ 157.56M | 2.83 | $ 55.76M |
9/30/2023 | $ 94.33M | 1.29 | $ 72.85M |
6/30/2023 | $ 142.1M | 1.52 | $ 93.55M |
3/31/2023 | $ 181.58M | 2.7 | $ 67.32M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ZYMEWORKS INC is calculated as follows: CashnEq [ $ 244.12M ] / LiabilitesC [ $ 96.89M ]
(=) Cash Ratio [ 2.52 ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |